Kuros BioSciences AG

Kuros BioSciences AG is located in Schlieren, Switzerland on Wagistrasse 25. Kuros BioSciences AG is rated 3.6 out of 5 in the category laboratory in Switzerland. OUR AIM Our aim is to deliver decreased complications, advanced functional rehabilitation and to eliminate non-unions for spine surgeons and their patients. OUR CONTRIBUTION With more than 150 years of combined research experience, we feel well-established as leaders in orthobiologics, but we’re never content with resting on our laurels. Instead, we continue to forge beyond the accepted solutions for spinal fusion. OUR FOCUS Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing. OUR PIONEERING TECHNOLOGY Surface technologies: We recently launched MagnetOs, a unique bone graft with submicron surface topography, that harnesses the power of osteoimmunology to deliver uniform, solid and stable spinal fusions. Drug-biologic combinations: The U.S. Food and Drug Administration (FDA) has approved an IND for the investigation of our Fibrin-PTH (KUR-113) product candidate; the first ever drug-biologic combination for spinal interbody fusion. Fibrin-PTH (KUR-113) is entering a Phase 2a clinical trial in the U.S. CONTACT KUROS TO FIND OUT MORE >>>>